These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27623022)

  • 81. Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies.
    Faheem ; Karan Kumar B; Chandra Sekhar KVG; Chander S; Kunjiappan S; Murugesan S
    RSC Adv; 2021 Mar; 11(20):12254-12287. PubMed ID: 35423735
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Generation of C5-desoxy analogs of tetrahydroisoquinoline alkaloids exhibiting potent DNA alkylating ability.
    Tanifuji R; Tsukakoshi K; Ikebukuro K; Oikawa H; Oguri H
    Bioorg Med Chem Lett; 2019 Jul; 29(14):1807-1811. PubMed ID: 31109792
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tropylium-Promoted Oxidative Functionalization of Tetrahydroisoquinolines.
    Oss G; de Vos SD; Luc KNH; Harper JB; Nguyen TV
    J Org Chem; 2018 Jan; 83(2):1000-1010. PubMed ID: 29231724
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genome-Directed Discovery of Tetrahydroisoquinolines from Deep-Sea Derived
    Yang J; Song Y; Tang MC; Li M; Deng J; Wong NK; Ju J
    J Org Chem; 2021 Aug; 86(16):11107-11116. PubMed ID: 33770435
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibitory activities of bipyrazoles: a patent review.
    Abbas AA; Abdellattif MH; Dawood KM
    Expert Opin Ther Pat; 2022 Jan; 32(1):63-87. PubMed ID: 34232805
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transcription factors as therapeutic targets in CNS disorders.
    Kane MJ; Citron BA
    Recent Pat CNS Drug Discov; 2009 Nov; 4(3):190-9. PubMed ID: 19891598
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Therapeutic applications of the versatile fatty acid mimetic WY14643.
    Pollinger J; Merk D
    Expert Opin Ther Pat; 2017 Apr; 27(4):517-525. PubMed ID: 27967266
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reductive inactivation of the hemiaminal pharmacophore for resistance against tetrahydroisoquinoline antibiotics.
    Wen WH; Zhang Y; Zhang YY; Yu Q; Jiang CC; Tang MC; Pu JY; Wu L; Zhao YL; Shi T; Zhou J; Tang GL
    Nat Commun; 2021 Dec; 12(1):7085. PubMed ID: 34873166
    [TBL] [Abstract][Full Text] [Related]  

  • 89. 3',4'-Dihydro-2'H-spiro[indoline-3,1'-isoquinolin]-2-ones as potential anti-cancer agents: synthesis and preliminary screening.
    Lobe MMM; Efange SMN
    R Soc Open Sci; 2020 Jan; 7(1):191316. PubMed ID: 32218955
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Terpenes with Antitumor Activity: A Patent Review.
    de Vasconcelos Cerqueira Braz J; Carvalho Nascimento Júnior JA; Serafini MR
    Recent Pat Anticancer Drug Discov; 2020; 15(4):321-328. PubMed ID: 33138764
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [2 + 3] Annulative Coupling of Tetrahydroisoquinolines with Aryliodonio diazo compounds To Access 1,2,4-Triazolo[3,4-
    Ansari MA; Khan S; Ray S; Shukla G; Singh MS
    Org Lett; 2022 Aug; 24(32):6078-6082. PubMed ID: 35925810
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Emerging Drugs for the Treatment of Cancer Pain: A Review of Patent Literature in 2014.
    Anderson B; Lee S; Abd-Elsayed A
    Recent Pat Anticancer Drug Discov; 2017; 12(2):169-173. PubMed ID: 28393711
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Progress in the Total Synthesis of Antitumor Tetrahydroisoquinoline Alkaloids.
    Gao Y; Tu N; Liu X; Lu K; Chen S; Guo J
    Chem Biodivers; 2023 May; 20(5):e202300172. PubMed ID: 36939065
    [TBL] [Abstract][Full Text] [Related]  

  • 94. I
    Zhuang SY; Tang YX; Liu JY; Chen XL; Ma JT; Wu YD; Zheng KL; Wu AX
    Org Lett; 2022 Apr; 24(15):2858-2862. PubMed ID: 35394795
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Direct and Efficient C(sp
    Yu H; Kim H; Baek SH; Lee D
    Front Chem; 2020; 8():629. PubMed ID: 32850649
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Transformation of Renieramycin M into Renieramycins T and S by Intramolecular Photoredox Reaction of 7-Methoxy-6-methyl-1,2,3,4-tetrahydroisoquinoline-5,8-dione Derivatives.
    Yokoya M; Yamazaki-Nakai M; Nakai K; Sirimangkalakitti N; Chamni S; Suwanborirux K; Saito N
    J Nat Prod; 2023 Jan; 86(1):222-231. PubMed ID: 36631738
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Resveratrol derivatives: an updated patent review (2012-2015).
    Li C; Xu X; Tao Z; Sun C; Pan Y
    Expert Opin Ther Pat; 2016 Oct; 26(10):1189-1200. PubMed ID: 27449285
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Steroidomimetic Tetrahydroisoquinolines for the Design of New Microtubule Disruptors.
    Leese MP; Jourdan F; Dohle W; Kimberley MR; Thomas MP; Bai R; Hamel E; Ferrandis E; Potter BV
    ACS Med Chem Lett; 2012 Jan; 3(1):5-9. PubMed ID: 22247790
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Single step syntheses of (1S)-aryl-tetrahydroisoquinolines by norcoclaurine synthases.
    Roddan R; Sula A; Méndez-Sánchez D; Subrizi F; Lichman BR; Broomfield J; Richter M; Andexer JN; Ward JM; Keep NH; Hailes HC
    Commun Chem; 2020 Nov; 3(1):170. PubMed ID: 36703392
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Recent patents on bacterial proteins as potential anticancer agents.
    Fialho AM; Chakrabarty AM
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):224-34. PubMed ID: 18221065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.